P/O-279 A randomized, placebo-controlled study of H_4R antagonist, JNJ-39758979, in atopic dermatitis (AD)

スポンサーリンク

概要

• 論文の詳細を見る
• 一般社団法人日本アレルギー学会の論文
• 2013-04-10

著者

• OHTSUKI Mamitaro

  Jichi Medical School

• Murata Yoko

  Janssen Pharmaceutical K.K.

• Song Michael

  Janssen R&D

• Hisamichi Katsuya

  Janssen Pharmaceutical K.K.

• Xu Xie

  Janssen R&D

• Greenspan Andrew

  Janssen R&D

• Thurmond Robin

  Janssen R&D

• Kikuchi Hisayuki

  Janssen Pharmaceutical K.K.

• Kato Mai

  Janssen Pharmaceutical K.K.

• Furue Masutaka

  Kyushu University

• Xu Xie

  Janssen R&D

• Thurmond Robin

  Janssen R&D

• Greenspan Andrew

  Janssen R&D

• Ohtsuki Mamitaro

  Jichi Medical University

関連論文

• Long-Term Continuous versus Intermittent Cyclosporin : Therapy for Psoriasis
• Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis : Efficacy and safety results from a Phase II/III randomized controlled study
• P/O-279 A randomized, placebo-controlled study of H_4R antagonist, JNJ-39758979, in atopic dermatitis (AD)

スポンサーリンク